Congenital heart defects (CHDs) affect the structure of the heart or nearby blood vessels from birth. Some defects are relatively mild and require only regular monitoring, while others need catheter-based procedures or open-heart surgery. For many families, the idea of heart surgery can be frightening, particularly when the patient is a newborn or young child.
Fortunately, advances in congenital heart disease treatment are creating new possibilities. Minimally invasive procedures are allowing doctors to treat selected heart defects through small incisions or blood vessels, sometimes avoiding the need to open the chest. These techniques may reduce recovery time and hospital stays for suitable patients.
But minimally invasive treatment is not appropriate for every congenital heart defect. The best approach depends on the heart's anatomy, the patient's age, the severity of the condition, and the experience of the medical team.
So, what is changing in minimally invasive surgery for CHDs, and what might the future hold?
What Is Minimally Invasive Surgery for CHDs?
Minimally invasive heart treatment refers to procedures designed to correct a heart problem while limiting the amount of surgical access required.
Traditional open-heart surgery often involves opening the chest to reach the heart. Depending on the procedure, the surgeon may also need to use a heart-lung machine temporarily to support circulation while the heart is being repaired.
Minimally invasive approaches may use smaller chest incisions or catheters inserted through blood vessels, commonly in the groin.
These approaches include:
- Catheter-based interventions: Doctors guide thin tubes through blood vessels to reach the heart.
- Device closure: A small device is used to close certain abnormal openings in the heart.
- Balloon procedures: A balloon is inflated to widen a narrowed valve or blood vessel.
- Stent placement: A small mesh tube helps keep a narrowed blood vessel open.
- Selected minimally invasive surgical repairs: Surgeons access the heart through smaller incisions rather than a full chest opening.
Although these techniques are often grouped together, they are not identical. A catheter-based procedure may avoid an incision in the chest altogether, while minimally invasive surgery still involves an operation.
The American Heart Association describes therapeutic cardiac catheterization as a way to treat selected heart defects without surgically opening the chest or heart. <Cite refs={["turn659586search0"]}/>
1. Catheter-Based Treatment Is Expanding
One of the most important developments in congenital heart disease care is the growing range of problems that can be treated in a cardiac catheterization laboratory.
During a catheter procedure, a specialist inserts a thin, flexible tube into a blood vessel and guides it toward the heart using medical imaging.
Depending on the diagnosis, the doctor may use the catheter to deliver a device, widen a narrowed structure, or improve blood flow.
Closing holes in the heart
Some atrial septal defects (ASDs), which are openings between the heart's upper chambers, can be closed using a small device delivered through a catheter.
The device is positioned across the opening and remains in place to help seal it as tissue grows over it.
Selected ventricular septal defects (VSDs) may also be suitable for catheter-based closure, although many VSDs require monitoring or surgical treatment instead.
Not every opening can be treated this way. Its size, location, surrounding tissue, and relationship to nearby valves and blood vessels all influence the decision.
Treating narrowed valves
Balloon valvuloplasty is another established catheter-based technique.
A balloon is guided to a narrowed heart valve and inflated to widen the opening. It may be used for certain cases of pulmonary or aortic valve stenosis.
The goal is to improve blood flow and reduce the extra work required from the heart.
These procedures demonstrate how some patients can receive treatment without traditional open-heart surgery. <Cite refs={["turn659586search0"]}/>
2. Smaller Incisions and Less Invasive Surgical Techniques
Not every CHD can be treated through a blood vessel. Some defects require a surgeon to repair or reconstruct the heart's structures directly.
For selected patients, surgeons may use smaller incisions to access the heart. The exact technique depends on the defect and the patient's anatomy.
Potential benefits include:
- Smaller surgical scars
- Less disruption of chest tissues
- Reduced postoperative discomfort in some cases
- Potentially shorter recovery
- Earlier return to certain everyday activities
However, a smaller incision does not automatically make an operation safer or better. Some complex defects are best treated through conventional open-heart surgery because the surgeon needs a clear view and sufficient access to perform a precise repair.
The priority is always an effective and durable correction of the heart defect—not simply the smallest possible incision.
3. Robotic-Assisted Congenital Heart Surgery
Robotic-assisted surgery is an emerging area of interest in congenital cardiac care.
In robotic-assisted procedures, the surgeon controls specialized instruments from a console. The instruments enter the body through small openings and can provide precise movements and a magnified view of the surgical area.
Robotic approaches have been used for selected cardiac procedures, but their role in congenital heart defect repair remains limited and highly dependent on the patient's anatomy, age, and the expertise available at the hospital.
A 2025 report describing an early robotic congenital cardiac surgery program included both pediatric and adult patients, illustrating that this approach is being explored in carefully selected cases. However, an early study does not establish that robotic surgery is appropriate for most children with CHD. <Cite refs={["turn659586search15"]}/>
Robotic surgery also requires specialized equipment, training, and a coordinated operating team. These requirements can limit availability.
For now, robotic-assisted repair should be viewed as a developing option rather than a replacement for conventional congenital heart surgery.
4. Better Imaging Helps Doctors Plan Procedures
Modern imaging plays a major role in making minimally invasive heart treatment possible.
Before treatment, doctors need to understand the exact shape of the defect, the surrounding structures, and how blood moves through the heart.
Echocardiography, cardiac CT, MRI, and imaging performed during catheterization can help clinicians build a detailed picture of the heart.
This information can help the team determine whether a catheter-based procedure is feasible, identify potential risks, and select the most appropriate device or surgical approach.
For complex congenital heart defects, three-dimensional imaging and computer-based models may also help clinicians visualize unusual anatomy and plan difficult repairs.
Better imaging does not eliminate all uncertainty, but it can improve procedural planning and support more individualized treatment.
5. Personalized Treatment Is Becoming More Important
There is no single minimally invasive technique that works for every CHD.
A small ASD, a narrowed pulmonary valve, and a complex defect involving several chambers of the heart require very different approaches.
Treatment decisions take into account:
- The specific heart defect
- The size and location of the abnormality
- The patient's age and body size
- Heart function and blood flow
- Previous procedures or surgeries
- Other medical conditions
- The likelihood of needing further treatment
- The experience of the treating center
For example, a catheter-based device may be an excellent option for a suitable ASD, while another patient with an ASD and additional heart abnormalities may benefit more from surgery.
The 2025 adult congenital heart disease guidelines emphasize the importance of appropriate expertise and individualized procedural planning. <Cite refs={["turn659586search11"]}/>
This approach helps ensure that new technology is used when it offers meaningful benefits rather than simply because it is available.
6. What Are the Benefits of Minimally Invasive CHD Treatment?
For appropriately selected patients, minimally invasive procedures may offer several advantages.
Shorter hospital stays
Some catheter-based procedures allow patients to return home the same day or after a short period of observation. Others require an overnight stay or longer monitoring, depending on the patient's condition.
Faster recovery
Because catheter procedures generally avoid a large chest incision, recovery may be easier than after open-heart surgery.
Smaller scars
Many catheter procedures leave only a small mark where the blood vessel was accessed. Selected minimally invasive surgical techniques may also result in smaller scars.
Reduced disruption to surrounding tissues
Some procedures avoid opening the chest, potentially reducing tissue disruption.
However, these benefits vary by procedure and patient. A minimally invasive approach does not guarantee less pain, fewer complications, or a shorter recovery in every case.
The suitability of the procedure and the quality of the repair remain more important than the size of the incision. <Cite refs={["turn659586search0","turn659586search11"]}/>
7. What Are the Risks and Limitations?
Minimally invasive procedures are still medical interventions and carry risks.
Possible complications include bleeding, infection, blood vessel injury, abnormal heart rhythms, device-related problems, and incomplete correction of the defect.
Catheter-based procedures also involve considerations such as exposure to X-rays, contrast dye when used, and the possibility that a procedure may not achieve the intended result.
Some patients need another catheter procedure or surgery later.
There are also anatomical limitations. Certain defects are too large, too complex, or too close to important heart structures for a catheter-based approach to be suitable.
In children, body size can present additional challenges because blood vessels are small and the heart is still growing. A device that works well in one patient may not be appropriate for another.
Families should ask the cardiology team about the expected benefits, possible complications, alternatives, and likelihood of future procedures.
8. What Happens After a Minimally Invasive Procedure?
Recovery depends on the type of treatment and the patient's overall health.
After catheterization, the healthcare team monitors the patient's heart rhythm, circulation, and the site where the catheter entered the blood vessel.
Patients are given instructions about activity, wound care, medications, and symptoms that require medical attention.
After device closure, doctors may use echocardiography or other tests to check the device's position and evaluate blood flow.
Following balloon treatment or stent placement, additional monitoring helps determine whether the treated valve or vessel remains open and whether further intervention may be necessary.
Parents should contact their child's healthcare team if they notice persistent bleeding, increasing swelling at the access site, fever, chest pain, or other concerning symptoms. Severe breathing difficulty, collapse, or other signs of an emergency require immediate medical attention.
Most importantly, minimally invasive treatment does not necessarily mean that follow-up care ends. Many people with congenital heart defects need ongoing cardiology appointments throughout their lives.
9. What Is Next for Minimally Invasive CHD Treatment?
Future developments are likely to focus on making procedures more precise, improving device design, and expanding treatment options for carefully selected patients.
Improved catheter technology
Smaller, more flexible catheters and improved delivery systems may make it easier to reach difficult areas of the heart.
More advanced imaging
Better three-dimensional imaging and real-time guidance may help clinicians understand complex anatomy and position devices more accurately.
New devices for difficult defects
Researchers continue to investigate devices and catheter techniques that may help treat conditions that currently require surgery. Each new approach needs appropriate evaluation to establish safety, effectiveness, and durability.
Greater use of individualized planning
Advances in computer modeling and simulation may help specialists plan procedures around the unique anatomy of each patient.
Better long-term evidence
As new techniques are introduced, researchers need to study not only immediate results but also how well repairs last over many years.
This is particularly important for children, whose hearts and blood vessels grow over time. A treatment that works well in the short term must also be assessed for its long-term effects.
Progress will depend on careful research, specialist training, and follow-up—not technology alone.
10. Questions Families Should Ask the Heart Team
If a child or adult with CHD is being considered for a minimally invasive procedure, families can prepare for the consultation by asking:
- What exactly is the heart defect, and how serious is it?
- Is a catheter-based procedure or minimally invasive surgery appropriate?
- What are the benefits compared with open-heart surgery?
- What risks are specific to this patient?
- How experienced is the team with this procedure?
- How long is the expected hospital stay and recovery?
- Could another procedure or surgery be needed later?
- What follow-up care will be required?
Clear answers can help families understand their options and participate in informed decisions.
Conclusion: A Promising Future, With the Right Treatment for Each Patient
Minimally invasive surgery and catheter-based interventions are changing the way some congenital heart defects are treated. For selected patients, these approaches can reduce the need for large incisions, shorten recovery, and make it possible to correct certain heart problems without traditional open-heart surgery.
Advances in imaging, catheter technology, device design, and robotic-assisted techniques may expand the available options in the coming years.
However, minimally invasive treatment is not suitable for every heart defect, and newer technology is not automatically better. Complex congenital heart conditions may still require conventional surgery, sometimes with several procedures over a patient's lifetime.
The most important goal is to choose a treatment that safely corrects the defect and provides the best possible long-term outcome.
With expert assessment, individualized care, and continued research, minimally invasive approaches are likely to remain an important and evolving part of congenital heart disease treatment.
Medical disclaimer: This article is intended for general educational purposes and does not replace professional medical advice. Treatment options and risks vary by diagnosis, age, anatomy, and overall health. Patients and families should discuss individual treatment decisions with a qualified congenital cardiology and cardiac surgery team.